Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs HAS✓SelectedUSD · HASGSK vs HAS performance historyLatest closeAs of-2.71%09/08
Stock and ETF performance explorer

GSK vs HAS

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+76.8%
HAS return
+53.3%
Excess return
+23.5%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioHASExcessAlpha
1D-2.7%-2.4%-0.3%-2.4%
7D-4.2%-3.1%-1.1%-3.8%
30D-7.5%-2.7%-4.8%-7.2%
3M-3.3%+8.9%-12.2%-4.5%
6M-9.3%-2.9%-6.4%-9.2%
YTD+1.6%+12.6%-11.0%-0.4%
1Y+25.5%+17.5%+8.0%+22.2%
3Y+49.3%+46.2%+3.1%+39.4%
5Y+46.7%+12.6%+34.1%+41.3%
10Y+76.8%+55.7%+21.1%+57.8%
All+76.8%+53.3%+23.5%+57.8%

Cumulative growth

Daily Returns

Daily percentage return beside HAS.

Daily Out/Under-Performance

Portfolio return minus HAS return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × HAS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded HAS wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling